SAUDI ARABIA AND MIDDLE EAST RADIOISOTOPE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Saudi Arabia and Middle East Radioisotope Market, By Radioisotopes (Molebdennum 99/Technetium-99, Iodine-131, Iodine-125, Yttrium-90, Strontium-89, Cesium-137, Cobalt-60, Iridium-192, Selenium-75, Lutetium 177, Germanium-68/gallium-68, Nickel-63, Copper-67, Scandium 47, Phosphorus-32, Holmium 166, Chromium 51, Samarium 153, Rhenium-188, Terbium-161, Radium -226, Rhenium-186, Actinium-225, and Others), By Application (Medical Application (Medical Imaging, Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), Radiation Therapy (Gamma radiotherapy, Brachytherapy, Targeted-Alpha-Therapy (TAT)), Clinical Research (Cell Biology, Drug Development, Metabolic Pathway Study) and Industrial Application (Inspection/Monitoring, Measuring, Quality Control and Testing, Sterilization, Food Preservation), By End User (Hospitals, Imaging Centers, Research Centers, Biopharmaceutical Companies, Food Industry, Chemical Industry, and Others)

Recent Developments:

Acquisition, Collaboration, and Partnerships:

In April 2023, Abdulla Fouad Group, a business group, and ORYX Isotopes, a provider of latest radiopharmaceuticals, and AlMoosa Specialized Hospital, a specialty hospital, announced a collaboration to establish a private pharmaceuticals production facility equipped with a Cyclotron, in the Eastern Province of Saudi Arabia. Cyclotrons play a crucial role in preparing a diverse range of radionuclides, which find applications in single photon emission computed tomography (SPECT) and positron emission tomography (PET). The demand for radiopharmaceutical production using cyclotron-produced radioisotopes is on the rise in Saudi Arabia.